AR088369A1 - Sistema de administracion de farmaco de dos fases - Google Patents
Sistema de administracion de farmaco de dos fasesInfo
- Publication number
- AR088369A1 AR088369A1 ARP120103874A ARP120103874A AR088369A1 AR 088369 A1 AR088369 A1 AR 088369A1 AR P120103874 A ARP120103874 A AR P120103874A AR P120103874 A ARP120103874 A AR P120103874A AR 088369 A1 AR088369 A1 AR 088369A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogel
- particles
- active ingredient
- phase
- administration system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Abstract
Reivindicación 1: Una composición farmacéutica para la administración oral, que comprende: un hidrogel semisólido que tiene un contenido de agua de al menos el 20% en peso, en base al peso total del hidrogel, una pluralidad de partículas recubiertas que contienen ingrediente activo dispersas en dicho hidrogel, donde se activa la desintegración o disolución del recubrimiento de dichas partículas por exposición a un rango de pH particular y como resultado el ingrediente activo es liberado, y el hidrogel tiene un pH lo suficientemente diferente del pH que activa la desintegración o disolución del recubrimiento de las partículas para evitar la liberación del ingrediente activo de las partículas en el hidrogel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161548837P | 2011-10-19 | 2011-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088369A1 true AR088369A1 (es) | 2014-05-28 |
Family
ID=48135086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120103874A AR088369A1 (es) | 2011-10-19 | 2012-10-18 | Sistema de administracion de farmaco de dos fases |
Country Status (9)
Country | Link |
---|---|
US (1) | US9314441B2 (es) |
EP (1) | EP2768488A4 (es) |
JP (1) | JP2014530855A (es) |
CN (1) | CN103957894A (es) |
AR (1) | AR088369A1 (es) |
AU (1) | AU2012326513B2 (es) |
BR (1) | BR112014009547A8 (es) |
CA (1) | CA2852447A1 (es) |
WO (1) | WO2013058996A1 (es) |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3419657A (en) | 1964-06-23 | 1968-12-31 | Dagra Nv | Iodopanoic acid in a hydrogel |
US4837255A (en) | 1987-03-10 | 1989-06-06 | Ciba-Geigy Corporation | Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
US5030454A (en) * | 1987-10-26 | 1991-07-09 | Alza Corporation | Method for delivering drug in tiny pills in liquid carrier |
JPH04149716A (ja) * | 1990-10-15 | 1992-05-22 | Fujitsu Ltd | 情報処理装置 |
EP0596962A4 (en) * | 1991-07-24 | 1997-01-15 | Enzacor Pty Ltd | Therapeutic compositions and methods. |
US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
IL108366A (en) | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
IT1273742B (it) * | 1994-08-01 | 1997-07-09 | Lifegroup Spa | Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose |
DE19529862A1 (de) | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
US6365180B1 (en) | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
CA2243619A1 (fr) | 1998-07-17 | 2000-01-17 | Universite De Sherbrooke | Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines |
EP1124587A1 (en) * | 1999-08-27 | 2001-08-22 | Department of National Defence | Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
DE10224086A1 (de) | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
WO2004004690A1 (en) * | 2002-07-03 | 2004-01-15 | Abbott Laboratories | Liquid dosage forms of proton pump inhibitors |
US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
US20040265359A1 (en) | 2003-04-17 | 2004-12-30 | Sacks Gordon S. | Oral delivery formulations of L-glutamine |
US20080226705A1 (en) | 2004-03-31 | 2008-09-18 | Soltero Richard A | Gel delivery system for oral administration of medicaments |
WO2005107713A2 (en) | 2004-05-11 | 2005-11-17 | Egalet A/S | Swellable dosage form comprising gellan gum |
US9492400B2 (en) * | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
JP4987261B2 (ja) | 2005-07-13 | 2012-07-25 | 株式会社 メドレックス | ゲル状経口製剤 |
DOP2006000274A (es) | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
JP2007252341A (ja) * | 2006-03-24 | 2007-10-04 | Well Haamonii:Kk | 粉末嚥下補助食品 |
JP2008125435A (ja) * | 2006-11-21 | 2008-06-05 | Well Haamonii:Kk | ゲル形成性組成物及びこの組成物を含有するゲル |
US20080171110A1 (en) * | 2007-01-17 | 2008-07-17 | Geoffrey Catherwood Stuart | Solids package |
JP2009007262A (ja) * | 2007-06-26 | 2009-01-15 | Toyo Capsule Kk | ビスホスホネート製剤 |
JP5320091B2 (ja) * | 2009-02-02 | 2013-10-23 | 大蔵製薬株式会社 | 医薬成分が長期安定化された経口投与医薬ゼリー製剤 |
CA2838006C (en) * | 2011-06-07 | 2020-06-02 | Gelesis Ip, Lp | Method for producing hydrogels |
-
2012
- 2012-10-05 WO PCT/US2012/058829 patent/WO2013058996A1/en active Application Filing
- 2012-10-05 CN CN201280051084.0A patent/CN103957894A/zh active Pending
- 2012-10-05 AU AU2012326513A patent/AU2012326513B2/en active Active
- 2012-10-05 BR BR112014009547A patent/BR112014009547A8/pt not_active IP Right Cessation
- 2012-10-05 CA CA2852447A patent/CA2852447A1/en not_active Abandoned
- 2012-10-05 EP EP12842547.7A patent/EP2768488A4/en not_active Withdrawn
- 2012-10-05 JP JP2014537098A patent/JP2014530855A/ja active Pending
- 2012-10-09 US US13/647,816 patent/US9314441B2/en active Active
- 2012-10-18 AR ARP120103874A patent/AR088369A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112014009547A8 (pt) | 2018-01-23 |
US9314441B2 (en) | 2016-04-19 |
CA2852447A1 (en) | 2013-04-25 |
AU2012326513A1 (en) | 2014-05-01 |
AU2012326513B2 (en) | 2016-03-17 |
WO2013058996A1 (en) | 2013-04-25 |
EP2768488A1 (en) | 2014-08-27 |
EP2768488A4 (en) | 2015-04-15 |
US20130098797A1 (en) | 2013-04-25 |
JP2014530855A (ja) | 2014-11-20 |
CN103957894A (zh) | 2014-07-30 |
BR112014009547A2 (pt) | 2017-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
BR112015026549A2 (pt) | forma de dosagem à prova de violação contendo uma ou mais partículas | |
EA201400972A1 (ru) | Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения | |
BR112015023922A2 (pt) | composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes | |
BR112015022896A2 (pt) | drogas de alta penetração e suas composições para o tratamento de doenças de parkinson | |
BR112012018695A2 (pt) | compostos pirazol como antagonistas crth2 | |
JP2014218522A5 (es) | ||
GT201400059A (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos | |
BR112015030315A2 (pt) | derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo | |
BR112015024271A2 (pt) | sistema de fornecimento transdérmico | |
CO7160008A2 (es) | Derivados de estra- 1,3,5(10),16- tetraeno 3-sustituidos, métodos para su preparación, prepara-ciones farmaceúticas que los contienen, así como su uso para la preparación de medicamentos | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
BR112014014795A2 (pt) | sistema de pélete de multiunidade de liberação imediata | |
HRP20240166T1 (hr) | Postupak liječenja prader-willijevog sindroma | |
BR112017022846A2 (pt) | combinação de dose fixa inviolável que proporciona rápida liberação de dois fármacos de partículas diferentes | |
BR112013027486A2 (pt) | combinação de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor | |
BR112015030431A2 (pt) | formulação de liberação modificada | |
CL2009000330A1 (es) | Composicion farmaceutica que comprende microcapsulas de sabor enmascarado con un nucleo de ranitidina y al menos dos recubrimientos sobre el; tabla de rapida desintegracion oral; metodo para preparar la composicion farmaceutica; metodo para preparar la tableta, util para tratar o prevenir trastornos gastrointestinales. | |
BR112014009242A2 (pt) | nanossuspensão farmacêutica | |
HRP20201233T1 (hr) | Spoj izveden od pirazolina i njegova primjena u tjednom doznom režimu protiv upale i bola porijeklom od degenerativnog oboljenja zgloba kod sisavaca | |
BR112017022856A2 (pt) | combinação de dose fixa inviolável que proporciona rápida liberação de duas drogas a partir de partículas | |
AR088369A1 (es) | Sistema de administracion de farmaco de dos fases | |
BR112017022335A2 (pt) | combinação de dose fixa inviolável que fornece rápida liberação de dois fármacos a partir de partículas e matriz | |
BR112012020415A2 (pt) | composição farmacêutica para a prevenção ou tratamento da osteoartrite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |